Abstract A 63 year old man with central nervous system lupus with a neurogenic bladder and visual disturbance is described. The diagnosis of neurogenic bladder, attributed to peripheral neuropathy, was made on the basis of cystometrography and clinical symptoms. A brain magnetic resonance imaging scan showed gliosis along the cerebral vessels and the optic nerve. This case shows that systemic lupus erythematosus can be accompanied by a peripheral neurogenic bladder and visual disturbance, and that these symptoms may not improve despite the amelioration of other lupus symptoms on treatment with steroids.
It is rare for both the bladder and optic nerve to be affected in systemic lupus erythematosus (SLE) .' Involvement of the bladder may be manifested by lupus cystitis and neurogenic bladder, which may be caused by an upper motor neurone disturbance. The latter is part of the myelopathy of the central nervous system as a result of lUpUS.3 3 Central nervous system lupus may also produce visual and neurological symptoms resembling multiple sclerosis. 4 We describe here a patient who developed simultaneously a neurogenic bladder caused by a lower motor neurone disturbance and visual disturbance. This is believed to be the first report of such a case.
positive, and antinuclear antibodies positive at a titre of 1/2520. Tests were negative for antibodies to ribonucleoprotein, Sm, SS-A, SS-B, Sc1-70, and Jo-1. Unclassified antibody to extractable nuclear antigens was positive. Antibodies to DNA were 600 U/ml (normal <20 A neurological examination showed hyperactive deep tendon reflexes of the lower legs, and a positive bilateral Babinski reflex. There was no evidence of sensory neuropathy. Examination of the cranial nerves showed right lower medial defects in both visual fields. The patient was unaware ofany visual disorder. There was no papilloedema. Urine analysis showed microscopic haematuria and proteinuria of 0-5-1-0 g/day; the urine sediment contained some granular casts. The packed cell volume was 0-28. The white cell count was 3 1 x 109/1 (neutrophils 58%, lymphocytes 20%). The serum protein was 60 g/l (albumin 25 g/l, y globulin 12 g/l). Serological testing was negative for C reactive protein (1-0 mg/i) and the erythrocyte sedimentation rate was 33 mm/h. Rheumatoid factor was 113 U/ml, lupus erythematosus test antibodies to DNA, and 28 U/ml for antibodies to CH50. There was no proteinuria. A follow up magnetic resonance imaging scan of his brain performed 18 months later showed an increase in the size and number of high intensity lesions, indicating that the gliosis rapidly increased. This differs from the clinical course of arteriosclerosis (Fig 2A and B) . The patient could urinate 50 ml voluntarily but cystometrography showed no appreciable improvement. Pyramidal tract signs and the visual disturbance also did not improve despite the treatment with prednisolone and methylprednisolone.
Discussion
Neurological disorders occur in about 10-20% of patients with SLE' 8 with convulsions (9 1%) and apoplexy (4-3%) being relatively common. The lower urinary tract is affected in only 1% of patients with SLE, and a definite diagnosis of neurogenic bladder has been reported in only three patients, who all had central nervous system lupus with an upper neurone disorder presenting as a symptom of transverse myelopathy, as shown in the table.2 3 The neurogenic bladder in our patient was a result of peripheral neuropathy as determined by the cystometrographic observations and clinical symptoms. Its pathogenesis was uncertain. The patient had no history of lumbar injury or operation. It should be emphasised that he had an acute onset of neurogenic bladder concomitant with an increase in SLE activity. The vasculitis of SLE was probably responsible for this neuropathy, though other causes cannot be excluded.
The visual field is rarely affected in SLE, with only eight patients describing conditions such as optic neuritis.4 However, none of these showed optic lesions on ordinary radiographs, and no definite diagnosis of optic neuritis was made before death. In our patient, we detected high intensity lesions in the optic nerve which contributed to the clinical visual defects, as shown by a T2 weighted image of the brain by magnetic resonance imaging. Magnetic resonance imaging was also useful in diagnosing central nervous system lupus in this patient because similar lesions were observed along the vessels in the bilateral deep white matter and basal ganglia.6 ' Central nervous system lupus should be differentiated from multiple sclerosis in which optic nerve involvement, known as Devic's syndrome, is common. The distribution of the gliosis detected by magnetic resonance imaging could aid the differential diagnosis of these two diseases: in multiple sclerosis it tends to be limited to the white matter of the cerebrum and not present along the vessels. 6 7 In this patient low levels of complement in the cerebrospinal fluid also supported the diagnosis of central nervous system lupus.' 10 In this instance the diagnosis of central nervous system lupus was made, unusually, in an elderly man. Catoggio 
